| Literature DB >> 33643685 |
Noam Morningstar-Kywi1, Rory E Kim1.
Abstract
Teaching of clinical decision-making is an important component of health professions education. Patient case examples are widely used in didactic coursework to teach this material, but engaging all learners in large, lecture-based courses remains a challenge. Interactive fiction (IF), a digital choose-your-own-adventure media, provides an accessible way for students to individually explore the narrative of a patient-case in a safe environment. Here, we report the development of interactive, digital patient-cases (eCases) using Twine, a free IF development platform. Fourteen eCases were developed in collaboration with 11 faculty members and were used in seven different PharmD courses over three semesters. eCase content was developed by faculty members for their respective instructional topics and accessed via Web browsers on students' personal electronic devices. eCases were received positively by students, with > 90% of students reporting that eCases were easy to use, helped them learn the material at their own pace, and gave them an opportunity to learn from mistakes. Student self-perceived confidence also increased significantly after eCase use. Faculty reported that eCases took more time to develop than conventional cases, but were easier to deliver and provided better student engagement. IF is an accessible media for creating and delivering low-fidelity interactive patient cases that can engage all students in a large class. eCases allow students to apply their knowledge, practice clinical decision-making, and safely learn from their mistakes. eCases are versatile and well suited for both in-person and virtual teaching across a variety of health professions programs to teach clinical decision-making. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40670-021-01245-7. © International Association of Medical Science Educators 2021.Entities:
Keywords: Active learning; Clinical decision-making; Educational technology; Interactive fiction; Pharmacy education; Simulation
Year: 2021 PMID: 33643685 PMCID: PMC7899795 DOI: 10.1007/s40670-021-01245-7
Source DB: PubMed Journal: Med Sci Educ ISSN: 2156-8650
eCases used in PharmD courses and other settings
| Topic | Course | Uses |
|---|---|---|
| Acute heart failure | Therapeutics: Cardiovascular System (P3) | 1 |
| Aminoglycoside dosing | Pharmacokinetics (P2) | 1 |
| Community-acquired pneumonia | Therapeutics: Infectious Diseases (P3) | 1 |
| Cough, cold, and flu | Non-Prescription Therapies (P1) | 1 |
| Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome | Therapeutics: Endocrine System (P2) | 1a |
| Malaria chemoprophylaxis | Community Pharmacy Practice (P2/P3) | 2 |
| Pharmacogenetics of acute coronary syndrome | PGxLEARN (CE) | 1 |
| Rheumatoid arthritis | Therapeutics: General Medicine and Inflammatory Disorders (P2) | 1 |
| Self-administered hormonal contraception | Community Pharmacy Practice (P2/P3) | 2 |
| Smoking cessation (state protocol) | Community Pharmacy Practice (P2/P3) | 2 |
| Smoking cessation (collaborative practice agreement) | Non-Prescription Therapies (P1) International Student Summer Program (UG) | 3a |
| Travel medicine | Community Pharmacy Practice (P2/P3) | 2 |
| Vancomycin dosing | Pharmacokinetics (P2) | 1 |
| Warfarin dosing | Therapeutics: Cardiovascular System (P3) | 1 |
P1 pharmacy year 1, P2 pharmacy year 2, P3 pharmacy year 3, UG undergraduate, CE continuing education
aIncludes use in virtual classroom sessions during COVD19 pandemic
Fig. 1Simplified diagram depicting the branching decision tree and multiple pathways for completing an eCase. Outcomes B and D represent the result of optimal choices, whereas as outcomes A and C result from suboptimal and inappropriate choices, respectively. In practice, the number of drug choices, iterations, and outcomes can be increased ad infinitum
PharmD student survey response rates
| Topic | Responsesa | Class sizeb |
|---|---|---|
| Acute heart failure | 8 | 185 |
| Aminoglycoside dosing | 17 | 196 |
| Community-acquired pneumonia | 16 | 187 |
| Cough, cold, and flu | 179 | 193 |
| Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome | 21 | 199 |
| Malaria chemoprophylaxis | 22 | 100c |
| Rheumatoid arthritis | 24 | 195 |
| Self-administered hormonal contraception | 22 | 100c |
| Smoking cessation (state protocol) | 22 | 100c |
| Smoking cessation (collaborative practice agreement) | 153 | 391c |
| Travel medicine | 22 | 100c |
| Vancomycin dosing | 17 | 196 |
| Warfarin dosing | 19 | 185 |
| Total | 542 |
aeCase and survey completion were not mandatory in all courses. Includes partial responses
bReflects enrollment in course and course-year (Table 1) at time of eCase administration
cFor eCases used multiple times, class size is the sum of all classes
Pooled student responses
| Question: This eCase… | SD | D | N | A | SA | Total |
|---|---|---|---|---|---|---|
| Was easy to use | 13 | 12 | 16 | 140 | 225 | 406a |
| Helped me to learn the material | 11 | 2 | 30 | 132 | 323 | 498 |
| Helped me to check my understanding of the material | 9 | 4 | 26 | 122 | 338 | 499 |
| Increased my confidence in applying my knowledge of the material | 10 | 17 | 39 | 123 | 216 | 405a |
| Allowed me to learn at my own pace | 9 | 7 | 25 | 132 | 325 | 498 |
| Gave me an opportunity to learn from mistakes | 9 | 4 | 18 | 100 | 272 | 403a |
Data are shown as the number of students in each category
SD strongly disagree, D disagree, N neither agree nor disagree, A agree, SA strongly agree
aThis question was not included on the survey disseminated with the first eCase deployed
Changes in student confidence
| Before completing the eCase | After completing the eCase | ||
|---|---|---|---|
| Smoking cessation (collaborative practice agreement) | |||
| Make an appropriate assessment | 3 (1) | 4 (0) | |
| Recommend treatment | 3 (2) | 4 (0) | |
| Cough, cold, and flu | |||
| Make an appropriate assessment | 3 (2) | 4 (1) | |
| Recommend treatment | 3 (1) | 4 (1) | |
| Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome | |||
| Make an appropriate assessment | 3 (3) | 4 (1) | |
| Recommend treatment | 3 (1) | 4 (2) |
All questions were in the form of a Likert-like scale evaluation from 1 = not confident to 5 = very confident. Results are expressed as a median (interquartile range). Differences in scores before using the eCase and after using the eCase were calculated using a Wilcoxon signed rank test
Faculty perceptions of development and utilization of eCases
| Relativea outcome | Much less | Somewhat less | About the same | Somewhat more | Much more |
|---|---|---|---|---|---|
| Time and effort | |||||
| Time to prepare before class | 2 | 2 | 2 | 2 | 1 |
| Effort to prepare before class | 1 | 3 | 1 | 2 | 2 |
| Time to deliver in class | 1 | 1 | 3 | 1 | 0 |
| Effort to deliver in class | 1 | 6 | 2 | 0 | 0 |
| Utility | |||||
| Facilitated engagement | 0 | 0 | 0 | 5 | 4 |
| Facilitated discussion | 0 | 0 | 0 | 6 | 2 |
| Provided formative feedback | 0 | 0 | 2 | 2 | 5 |
| Provided real-world application | 0 | 0 | 0 | 2 | 7 |
Data are shown as the number of faculty in each category (n = 9)
aRelative to ‘conventional’ case preparation and delivery. Conventional cases were defined as the style of patient cases used by responding faculty prior to using an eCase